Product Information
MOMETASONE FUROATE 0.1% OINT is a generic product labeled by Glenmark Pharmaceuticals Inc., USA, priced at $0.3420 per GM under NDC 68462022517. Its NADAC has been published 562 times since Nov 28, 2013.
Strength
1 mg/g
Manufacturer
Glenmark Pharmaceuticals Inc., USANDC
68462022517
Classification
Generic
Dosage Form
OINTMENT
Route
TOPICAL
Last Updated
8/21/2024
Active Ingredients
MOMETASONE FUROATEApproval Type
Generic (ANDA)
FDA Application
ANDA078571On Market Since
5/28/2008
Pharmacological Classes
Price Statistics
The NADAC for MOMETASONE FUROATE 0.1% OINT has been published 562 times since Nov 28, 2013, and over the history we have for it it has declined 17.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3420 per GM |
|---|---|
| All-time high | $0.6681 (Feb 12, 2014) |
| All-time low | $0.2383 (Jan 22, 2020) |
| Median price | $0.3362 |
| Average price | $0.3669 |
| Largest weekly change | +49.7% (Jan 22, 2014) |
| Weeks tracked | 562 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 35% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of MOMETASONE FUROATE 0.1% OINT?
The current National Average Drug Acquisition Cost (NADAC) for MOMETASONE FUROATE 0.1% OINT, manufactured by Glenmark Pharmaceuticals Inc., USA, is $0.3420 per GM (NDC 68462022517), effective Aug 28, 2024.
How has the price of MOMETASONE FUROATE 0.1% OINT changed over time?
Over the history we have for it, the NADAC for MOMETASONE FUROATE 0.1% OINT has declined 17.5%. It has been tracked across 562 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for MOMETASONE FUROATE 0.1% OINT?
Since Nov 28, 2013, the NADAC for MOMETASONE FUROATE 0.1% OINT has ranged from a low of $0.2383 (Jan 22, 2020) to a high of $0.6681 (Feb 12, 2014), with a median of $0.3362 per GM.
Are there cheaper alternatives to MOMETASONE FUROATE 0.1% OINT?
Yes. 1 NADAC-published product shares the same active ingredient, strength, and dosage form. The lowest-priced option, MOMETASONE FUROATE 0.1% OINT, is $0.2236 per GM — about 35% below MOMETASONE FUROATE 0.1% OINT.
Who manufactures MOMETASONE FUROATE 0.1% OINT?
MOMETASONE FUROATE 0.1% OINT (NDC 68462022517) is labeled by Glenmark Pharmaceuticals Inc., USA, and CMS classifies it as a generic product.
Related Drugs
Same classification